Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Kidney Injury
74%
Chronic Kidney Disease
71%
Peritoneal Dialysis
50%
Estimated Glomerular Filtration Rate
47%
Apolipoprotein L1 (APOL1)
44%
Kidney Disease
43%
Dialysis
42%
Hemodialysis
37%
Kidney Replacement Therapy
37%
Renal Association
35%
Peritoneal Dialysis Patients
28%
Kidney Disease Progression
27%
Immune Checkpoint Inhibitors
26%
Hemodialysis Patients
25%
End-stage Kidney Disease
24%
Refractory Heart Failure
22%
Retrospective Analysis
20%
Kidney Failure
20%
Epidemiology
20%
Inflammation
19%
Kidney Function
19%
Israel
19%
Hospitalization
18%
Heart Failure Patients
18%
Israeli
17%
Renal Transplant Recipients
17%
Europe
17%
Fibrosis
17%
Hair Straightening
17%
Finerenone
17%
Randomized Trial
17%
Primary Kidney Disease
16%
Intact Parathyroid Hormone (iPTH)
16%
Kidney
15%
Baseline Characteristics
14%
Risk Variant
14%
Multivariable
14%
Mortality Rate
14%
Congestive Heart Failure
13%
Survival Probability
12%
Kidney Transplantation
12%
Adverse Events
12%
COVID-19
11%
Sepsis
11%
Human Kidney
11%
Risk Factors
11%
Genetic Risk
11%
Diabetic Kidney Disease
11%
Renal Replacement Therapy
11%
Median Time
11%
Medicine and Dentistry
Nephropathy
100%
Chronic Kidney Disease
67%
Hemodialysis
65%
Acute Kidney Injury
59%
Renal Replacement Therapy
52%
Peritoneal Dialysis
50%
Glomerular Filtration Rate
44%
Kidney Function
40%
Apolipoprotein L1
35%
End Stage Renal Disease
29%
Congestive Heart Failure
27%
Kidney Transplantation
26%
Renal Failure
23%
Creatinine
23%
Prevalence
21%
Infection
20%
Genetics
20%
Cohort Effect
19%
Inflammation
17%
Finerenone
17%
Immune Checkpoint Inhibitor
17%
Kidney Graft
17%
Proteinuria
16%
Diseases
15%
COVID-19
13%
Survival Rate
13%
Allele
13%
Hazard Ratio
12%
Kidney Stone
11%
Nephrocalcinosis
11%
Cohort Analysis
11%
Podocyte
11%
Sepsis
11%
Glomerulonephritis
10%
Parathyroid Hormone
10%
Patient Referral
10%
Overall Survival
10%
Kidney Injury
10%
NLR Family Pyrin Domain containing 3
10%
Proportional Hazards Model
9%
Vitamin D
8%
Fibrosis
8%
Hyperparathyroidism
8%
Peritoneal Fluid
8%
Peritonitis
8%
Middle Age
8%
Oxygenase
8%
Epigenomics
8%
Creatinine Clearance
8%
Malignant Neoplasm
8%
